| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 76150 | Null | 0.0291420747327558 | 0.25955542 |
| NSC 107043 | Null | 0.029142074732756 | 0.17570118 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.029142074732756 | 0.43678545 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.029142074732756 | 0.007114551 |
| NSC 13484 | Null | 0.029142074732756 | 0.16617941 |
| NSC 149765 | 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) | 0.029142074732756 | 0.127716 |
| NSC 15795 | Null | 0.029142074732756 | 0.24979577 |
| NSC 164970 | Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- | 0.029142074732756 | 0.18365932 |
| NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.029142074732756 | 0.12913467 |
| NSC 346098 | Null | 0.029142074732756 | 0.039216719 |